title: The calcineurin inhibitor Ascomicin interferes with the early stage of the epileptogenic process induced by Latrunculin A microperfusion in rat hippocampus.
abstract: Latrunculin A microperfusion in rat hippocampus has shown to be an effective model of acute and chronic seizures for neurochemical studies. The intervention over early synaptic plasticity changes after the epileptogenesis onset represents a big challenge on the design of a suitable therapy to impair the epilepsy development. We previously suggested that receptor location might be essential for controlling neuronal excitability, and that disruption of local cytoskeletal dynamics followed by drastic changes in the synaptic/extrasynaptic ratio of NMDA, AMPA receptors and their subsequent downstream signalling may play an important role in the pathogenesis of seizures. In the present study, we performed a pharmacological intervention in the Latrunculin model by using Ascomicin (ASC) and Phenytoin (PHT). We pointed out the inhibitory action of ASC over the protein phosphatase 2B (PP2B). PP2B pathological mechanism involves changes in actin cytoskeleton and showed to avoid those subsequent changes previously observed in PSD components. On the contrary, PHT didn't seem to modify the F-actin depolymerization process induced, showing a similar redistribution pattern from the PSD towards the extrasynaptic site of several molecular components with more or less dependence on actin for their location, including glutamate receptors. Overall, we propose that the early intervention over changes on the synapse during the epileptogenic process might represent the best approach to avoid the onset of chronic refractory seizures our model. On this regard, the therapeutic potential of ASC, FK506 and derivatives should be further explored as a possible tool in the intervention over epilepsy and other brain diseases.
authors.affiliation: Department of Biochemistry and Molecular Biology, School of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain, cfreirecobo@gru.edu.
authors.forename: Carmen
authors.initials: C
authors.lastname: Freire-Cobo
authors.forename: Germán
authors.initials: G
authors.lastname: Sierra-Paredes
authors.forename: Manuel
authors.initials: M
authors.lastname: Freire
authors.forename: Germán
authors.initials: G
authors.lastname: Sierra-Marcuño
mesh_terms: D000818:Animals; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000633:toxicity*; D065095:Calcineurin Inhibitors / Q000008:administration & dosage*; D004827:Epilepsy / Q000139:chemically induced / Q000378:metabolism / Q000517:prevention & control*; D006624:Hippocampus / Q000187:drug effects* / Q000378:metabolism; D007260:Infusion Pumps; D008297:Male; D017551:Microdialysis / Q000379:methods; D051381:Rats; D017207:Rats, Sprague-Dawley; D016559:Tacrolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*; D053778:Thiazolidines / Q000633:toxicity*
chemical_list: D019086:Bridged Bicyclo Compounds, Heterocyclic; D065095:Calcineurin Inhibitors; D053778:Thiazolidines; C058028:immunomycin; C037067:latrunculin A; D016559:Tacrolimus
references.citation: Epilepsia. 2007;48 Suppl 1:14-8
references.pmid: 17316408
references.citation: J Neurosci. 2000 Jan 1;20(1):22-33
references.pmid: 10627577
references.citation: Neurobiol Dis. 2011 Aug;43(2):507-15
references.pmid: 21575722
references.citation: J Physiol. 1995 Jan 15;482 ( Pt 2):353-62
references.pmid: 7714826
references.citation: J Neurosci. 2004 Jul 14;24(28):6301-6
references.pmid: 15254085
references.citation: Neuron. 2000 Apr;26(1):197-205
references.pmid: 10798404
references.citation: Neuroscience. 1998 May;84(2):529-35
references.pmid: 9539223
references.citation: Science. 1995 Mar 10;267(5203):1510-2
references.pmid: 7878472
references.citation: Neuroscientist. 2002 Apr;8(2):154-73
references.pmid: 11954560
references.citation: J Neurosci. 1998 Dec 1;18(23):9835-44
references.pmid: 9822742
references.citation: Curr Drug Targets CNS Neurol Disord. 2003 Jun;2(3):153-62
references.pmid: 12769796
references.citation: Nat Rev Neurosci. 2010 Oct;11(10):682-96
references.pmid: 20842175
references.citation: J Neurosci. 2010 Nov 10;30(45):14937-42
references.pmid: 21068295
references.citation: Transplantation. 1998 Jan 15;65(1):18-26
references.pmid: 9448138
references.citation: J Neurochem. 2007 Aug;102(4):1329-45
references.pmid: 17663755
references.citation: Eur J Neurosci. 1998 May;10(5):1687-703
references.pmid: 9751141
references.citation: J Neurosci. 2000 Jun 15;20(12):4545-54
references.pmid: 10844024
references.citation: Epilepsia. 2011 Oct;52 Suppl 8:67-9
references.pmid: 21967368
references.citation: Nat Rev Neurol. 2009 Jul;5(7):380-91
references.pmid: 19578345
references.citation: Pharmacol Biochem Behav. 2006 Jul;84(3):511-6
references.pmid: 16872668
references.citation: Nat Med. 2005 Sep;11(9):973-81
references.pmid: 16116433
references.citation: J Cell Biol. 1972 Dec;55(3):696-711
references.pmid: 4656707
references.citation: Epilepsia. 2011 Jul;52(7):1292-6
references.pmid: 21480881
references.citation: Neuron. 2004 Sep 2;43(5):729-43
references.pmid: 15339653
references.citation: J Neurochem. 1985 Jul;45(1):276-83
references.pmid: 2987415
references.citation: Cell Mol Life Sci. 1999 Apr;55(4):549-53
references.pmid: 10357225
references.citation: Nat Neurosci. 2000 Dec;3(12):1282-90
references.pmid: 11100149
references.citation: Neuron. 2000 Oct;28(1):103-14
references.pmid: 11086987
references.citation: Science. 1999 Jun 11;284(5421):1811-6
references.pmid: 10364548
references.citation: J Neurosci. 2005 May 4;25(18):4649-58
references.pmid: 15872113
references.citation: Curr Opin Neurobiol. 2005 Feb;15(1):67-72
references.pmid: 15721746
references.citation: Neuron. 2000 Sep;27(3):539-50
references.pmid: 11055436
references.citation: Epilepsy Behav. 2011 Dec;22(4):617-40
references.pmid: 22056342
references.citation: Annu Rev Neurosci. 2005;28:25-55
references.pmid: 16029114
references.citation: Neurochem Int. 2007 Apr;50(5):734-40
references.pmid: 17316902
references.citation: Nat Neurosci. 2000 Dec;3(12):1291-300
references.pmid: 11100150
references.citation: J Mol Neurosci. 2006;28(2):151-60
references.pmid: 16679555
references.citation: Brain Res. 1994 Jun 20;648(2):337-41
references.pmid: 7522929
references.citation: Biochem Soc Trans. 2009 Dec;37(Pt 6):1147-60
references.pmid: 19909238
references.citation: Brain Res. 1975 Aug 15;93(3):485-9
references.pmid: 1182020
references.citation: Neuron. 1998 May;20(5):847-54
references.pmid: 9620690
references.citation: CNS Neurol Disord Drug Targets. 2007 Aug;6(4):288-300
references.pmid: 17691986
references.citation: Neuroscientist. 2010 Feb;16(1):28-39
references.pmid: 19429889
references.citation: J Neurosci Methods. 1996 Aug;67(2):113-20
references.pmid: 8872876
references.citation: J Neurosci. 2000 Oct 1;20(19):7246-51
references.pmid: 11007881
references.citation: Epilepsia. 2010 Apr;51(4):676-85
references.pmid: 20196795
references.citation: Expert Rev Neurother. 2008 Jun;8(6):907-15
references.pmid: 18505356
references.citation: Biochemistry. 1993 Jan 26;32(3):754-65
references.pmid: 7678499
references.citation: Biochem Biophys Res Commun. 2003 Nov 28;311(4):1159-71
references.pmid: 14623302
references.citation: CNS Neurosci Ther. 2008 Spring;14(1):36-46
references.pmid: 18482098
references.citation: J Physiol. 2007 Oct 15;584(Pt 2):509-19
references.pmid: 17717018
references.citation: Biochem Biophys Res Commun. 2006 Jan 13;339(2):687-94
references.pmid: 16332460
references.citation: J Neurosci. 2005 Mar 30;25(13):3442-51
references.pmid: 15800199
references.citation: Anal Biochem. 2007 Feb 15;361(2):305-7
references.pmid: 17181993
references.citation: Nat Rev Neurosci. 2007 Jun;8(6):413-26
references.pmid: 17514195
references.citation: J Biol Inorg Chem. 2010 Feb;15(2):283-9
references.pmid: 19862562
references.citation: Epilepsy Res. 2001 Sep;46(3):279-82
references.pmid: 11518629
references.citation: J Pharmacol Exp Ther. 1998 Jul;286(1):243-55
references.pmid: 9655866
references.citation: Epilepsia. 2010 Jul;51 Suppl 3:2-17
references.pmid: 20618393
references.citation: J Neurochem. 2001 Jul;78(2):304-15
references.pmid: 11461966
references.citation: Neuropharmacology. 2009 Feb;56(2):414-21
references.pmid: 18930747